Compile Data Set for Download or QSAR
Report error Found 178 Enz. Inhib. hit(s) with all data for entry = 9273
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454549BDBM454549(US10717746, Example 31a)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454548BDBM454548(US10717746, Example 31)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454544BDBM454544(US10717746, Example 27)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454543BDBM454543(US10717746, Example 26)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454542BDBM454542(US10717746, Example 25 | US10717746, Example 84)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454557BDBM454557(US10717746, Example 38)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454556BDBM454556(US10717746, Example 37)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454555BDBM454555(US10717746, Example 36)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454552BDBM454552(US10717746, Example 33 | US10717746, Example 35)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454553BDBM454553(US10717746, Example 34)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454552BDBM454552(US10717746, Example 33 | US10717746, Example 35)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454551BDBM454551(US10717746, Example 32)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454565BDBM454565(US10717746, Example 46)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454564BDBM454564(US10717746, Example 45)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454563BDBM454563(US10717746, Example 44)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454561BDBM454561(US10717746, Example 42)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454559BDBM454559(US10717746, Example 40 | US10717746, Example 41)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454559BDBM454559(US10717746, Example 40 | US10717746, Example 41)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454558BDBM454558(US10717746, Example 39)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454573BDBM454573(US10717746, Example 53)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454573BDBM454573(US10717746, Example 53)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454572BDBM454572(US10717746, Example 52)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454571BDBM454571(US10717746, Example 51a)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454570BDBM454570(US10717746, Example 51)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454570BDBM454570(US10717746, Example 51)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454569BDBM454569(US10717746, Example 50)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454567BDBM454567(US10717746, Example 48)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454567BDBM454567(US10717746, Example 48)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454566BDBM454566(US10717746, Example 47)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454580BDBM454580(US10717746, Example 60)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454578BDBM454578(US10717746, Example 58)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454577BDBM454577(US10717746, Example 57)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454576BDBM454576(US10717746, Example 56)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454575BDBM454575(US10717746, Example 55)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454575BDBM454575(US10717746, Example 55)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454525BDBM454525(US10717746, Example 8)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454586BDBM454586(US10717746, Example 68)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454585BDBM454585(US10717746, Example 67)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454584BDBM454584(US10717746, Example 66)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454521BDBM454521(US10717746, Example 4)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454601BDBM454601(US10717746, Example 65)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454520BDBM454520(US10717746, Example 3)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454583BDBM454583(US10717746, Example 64)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454519BDBM454519(US10717746, Example 2)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454582BDBM454582(US10717746, Example 63)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454533BDBM454533(US10717746, Example 16)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454591BDBM454591(US10717746, Example 76)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50528817BDBM50528817(CHEMBL4462530 | US10717746, Example 14 | US2023041...)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454590BDBM454590(US10717746, Example 75)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 454589BDBM454589(US10717746, Example 74)
Affinity DataIC50: 3nMAssay Description:Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

Displayed 1 to 50 (of 178 total ) | Next | Last >>
Jump to: